Related Experiment Videos
Oral acyclovir in immunocompetent patients with varicella
1University Hospital, Boston, Massachusetts.
The Annals of Pharmacotherapy
|February 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program.
The American journal of managed care·2000
Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
The American journal of cardiology·2000
Candesartan cilexetil: an angiotensin II receptor blocker.
The Annals of pharmacotherapy·2000
Retrospective case-control evaluation of the use of parenteral ketorolac tromethamine in patients after surgery.
American journal of therapeutics·1999
Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists.
The American journal of cardiology·1997
Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.
The American journal of cardiology·1997
Efficacy and Safety of Levetiracetam Versus Sodium Valproate in Pediatric Epilepsy: A Systematic Review and Meta-analysis.
The Annals of pharmacotherapy·2026
Doravirine/Islatravir: A 2-Drug Regimen for the Treatment of HIV-1 Infection.
The Annals of pharmacotherapy·2026
Obecabtagene Autoleucel in Relapsed/Refractory B-ALL: A Critical Review of Clinical Efficacy and Safety.
The Annals of pharmacotherapy·2026
Depemokimab-ulaa: A Long-Acting Interleukin-5 Inhibitor.
The Annals of pharmacotherapy·2026
Acute Myocarditis Presenting as Neck Pain With Severe Systemic Inflammation.
JACC. Case reports·2026
Proteomic Tear Fluid Analysis in Acute Anterior Uveitis Reveals Distinct Characteristics During Active Inflammation.
Ocular immunology and inflammation·2026
Myeloid Activator Protein-1 Complex Contributes to Salt-Sensitive Hypertension.
Circulation research·2026
Emerging therapeutic opportunities targeting nonclassical MHC-I molecules.
Trends in molecular medicine·2026